Evidence map›Paper›PMID 32690682›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Calcium-triggered fusion of lipid membranes is enabled by amphiphilic nanoparticles.

Mukarram A Tahir, Zekiye P Guven, Laura R Arriaga, Berta Tinao, Yu-Sang Sabrina Yang, Ahmet Bekdemir, Jacob T Martin, Alisha N Bhanji, Darrell Irvine, Francesco Stellacci and 1 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Rolling vesicles: From confined rotational flows to surface-enabled motion.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Curvature-Assisted Vesicle Explosion Under Light-Induced Asymmetric Oxidation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  10. Article
  11. Article
  12. Lymph node targeting for immunotherapy.Immuno-oncology technology · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Mukarram A TahirDepartment of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142.
Zekiye P GuvenInstitute of Materials, Ecole Polytechnique Federale de Lausanne, 1015 Lausanne, Switzerland.
Laura R ArriagaDepartment of Theoretical Condensed Matter Physics, Autonoma University of Madrid, 28049 Madrid, Spain; lrarriaga@quim.ucm.es aalexand@mit.edu.ORCID 0000-0002-3527-7953
Berta TinaoDepartment of Theoretical Condensed Matter Physics, Autonoma University of Madrid, 28049 Madrid, Spain.ORCID 0000-0002-3395-413X
Yu-Sang Sabrina YangKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
Ahmet BekdemirInstitute of Materials, Ecole Polytechnique Federale de Lausanne, 1015 Lausanne, Switzerland.
Jacob T MartinKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
Alisha N BhanjiDepartment of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142.
Darrell IrvineDepartment of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142.
Francesco StellacciInstitute of Materials, Ecole Polytechnique Federale de Lausanne, 1015 Lausanne, Switzerland.ORCID 0000-0003-4635-6080
Alfredo Alexander-KatzDepartment of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142; lrarriaga@quim.ucm.es aalexand@mit.edu.
Massachusetts Institute of Technology · USÉcole Polytechnique Fédérale de Lausanne · CHUniversidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipid membrane fusion is an essential process for a number of critical biological functions. The overall process is thermodynamically favorable but faces multiple kinetic barriers along the way. Inspired by nature's engineered proteins such as SNAP receptor [soluble N-ethylmale-imide-sensitive factor-attachment protein receptor (SNARE)] complexes or viral fusogenic proteins that actively promote the development of membrane proximity, nucleation of a stalk, and triggered expansion of the fusion pore, here we introduce a synthetic fusogen that can modulate membrane fusion and equivalently prime lipid membranes for calcium-triggered fusion. Our fusogen consists of a gold nanoparticle functionalized with an amphiphilic monolayer of alkanethiol ligands that had previously been shown to fuse with lipid bilayers. While previous efforts to develop synthetic fusogens have only replicated the initial steps of the fusion cascade, we use molecular simulations and complementary experimental techniques to demonstrate that these nanoparticles can induce the formation of a lipid stalk and also drive its expansion into a fusion pore upon the addition of excess calcium. These results have important implications in general understanding of stimuli-triggered fusion and the development of synthetic fusogens for biomedical applications.

Indexed as

CalciumCell MembraneGoldHumansLipid BilayersMembrane FusionMetal NanoparticlesMolecular Dynamics SimulationSNARE ProteinsTissue Array AnalysisCalciumGoldLipid BilayersSNARE Proteinsdrug deliverymembrane fusionnanoparticlesproteins

Identifiers

PMID32690682
PMCPMC7414053
OpenAlexW3036635453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.